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PUBLIC HEALTH COUNCIL 
MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH 
Henry I. Bowditch Public Health Council Room, 2
nd
 Floor 
250 Washington Street, Boston MA 
 
  
 
Docket:  Wednesday, February 14, 2018 - 9:00 AM 
  
 
1. ROUTINE ITEMS    
a. Introductions  
 
b. Updates from Commissioner Monica Bharel, MD, MPH 
 
c. Record of the Public Health Council January 10, 2018 Meeting (Vote) 
 
 
2. DETERMINATIONS OF NEED 
a. AdCare, Inc. application for a transfer of ownership to AAC Holdings, Inc. (Vote) 
 
b. Partners HealthCare, Inc. application for a transfer of ownership with respect to the change in 
corporate control of the Massachusetts Eye and Ear Infirmary (MEEI). (Vote) 
 
 
3. INFORMATIONAL PRESENTATIONS 
a. Informational presentation – Preventing foodborne illness:  an example of a coordinated public 
health response.  
  
 
 
The Commissioner and the Public Health Council are defined by law as constituting the Department of 
Public Health. The Council has one regular meeting per month. These meetings are open to public 
attendance except when the Council meets in Executive Session. The Council’s meetings are not hearings, 
nor do members of the public have a right to speak or address the Council. The docket will indicate 
whether or not floor discussions are anticipated. For purposes of fairness since the regular meeting is not 
a hearing and is not advertised as such, presentations from the floor may require delaying a decision 
until a subsequent meeting.  
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Public Health Council 
Attendance and Summary of Votes: 
Presented below is a summary of the meeting, including time-keeping, attendance and votes cast.  
Date of Meeting: Wednesday, February 14, 2018 
Start Time: 9:11am Ending Time: 11:40am 
 
Board Member Attended 
Record of the Public Health 
Council January 10, 2018 
Meeting (Vote) 
AdCare, Inc. 
application for a 
transfer of ownership 
to AAC Holdings, 
Inc. (Vote) 
Partners HealthCare, Inc. 
application for a transfer 
of ownership with respect 
to the change in corporate 
control of the 
Massachusetts Eye and 
Ear Infirmary (MEEI). 
(Vote) 
Monica Bharel 
Yes Yes Yes Yes 
Edward Bernstein 
Yes Yes Yes Yes 
Lissette Blondet 
Yes Yes Yes Yes 
Derek Brindisi Yes Yes Yes Yes 
Harold Cox Yes  Yes Yes Yes 
John Cunningham 
Yes Yes Yes Yes 
Michele David 
Yes Yes Yes Yes 
Meg Doherty 
Absent  Absent Absent Absent 
Michael Kneeland 
Absent Absent Absent Absent 
Joanna Lambert 
Yes Yes Yes Yes 
Paul Lanzikos 
Yes Yes Yes Yes 
Lucilia Prates-Ramos 
Absent Absent Absent Absent 
Secretary Francisco Ureña 
Absent Absent Absent Absent 
Alan Woodward 
Absent Absent Absent Absent 
Summary 
9 Members Present, 5 
Members Absent 
9 Members Approved, 
5members Absent  
9 members approved, 
5 members absent 
9 members approved, 5 
members absent 
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PROCEEDINGS 
A regular meeting of the Massachusetts Department of Public Health’s Public Health Council (M.G.L. c. 
17, §§ 1, 3) was held on Wednesday, February 14, 2018 at the Massachusetts Department of Public 
Health, 250 Washington Street, Henry I. Bowditch Public Health Council Room, 2nd Floor, Boston, 
Massachusetts 02108. 
 
Members present were: Monica Bharel, MD, MPH; Edward Bernstein, MD; Lissette Blondet; Derek 
Brindisi; Harold Cox; John Cunningham, PhD; Michele David, MD; Joanna Lambert and Paul Lanzikos. 
 
Absent member(s) were: Michael Kneeland, MD; Meg Doherty; Lucilia Prates-Ramos; Secretary 
Francisco Ureña; and Alan Woodward, MD. 
 
Also in attendance was Margret Cooke, General Counsel at the Massachusetts Department of Public 
Health. 
 
Commissioner Bharel called the meeting to order at 9:11 AM and made opening remarks before 
reviewing the agenda.  
 
ROUTINE ITEMS 
Updates from Commissioner Monica Bharel, M.D., MPH 
Commissioner Bharel began updates by giving a flu season update.    
The Commissioner announced that they recently confirmed first influenza-associated pediatric death 
this year in the state. The child was under the age of 10 and lived in Essex County. The child’s flu 
diagnosis was confirmed by clinical test and symptoms. She stated that this is a  tragic reminder of how 
serious the flu can be and her heart goes out to this family and those who have lost loved ones this 
season.   
Last flu season, there were two confirmed pediatric flu-related deaths in Massachusetts.  As of Feb. 3, 
the US Centers for Disease Control and Prevention had reported a total of 63 influenza-associated 
pediatric deaths this flu season nationwide. 
This flu season has been more severe than usual - locally and nationally - and we as a public health 
department are working hard to educate the public on steps they can take to prevent the spread of flu. 
In Massachusetts, the flu season started early. It started back in November, and has since increased in 
intensity. The department has been working with our community partners to survey hospitals and clinics 
to assess the impact of the flu and flu-like illness on their ability to treat patients, on staffing levels and 
on supply stocks to determine ways that the state can be helpful. 
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Earlier this week, Commissioner Bharel joined Dr. Al DeMaria, state epidemiologist and medical director 
of BIDLS, to record a video blog urging people to talk to their healthcare providers if they think they 
have the flu and stay home if they are ill with a fever, a cough or sore throat. We have also encouraged 
people to get vaccinated, to wash their hands thoroughly and regularly, or use hand sanitizer and to 
cover their coughs and sneezes. 
Flu is a very serious illness, particularly for the elderly and people with underlying health conditions. And 
every year, flu causes increased medical visits, hospitalizations, and unfortunately, even deaths. It 
should be taken seriously this year, next year and every year. 
Following flu updates, the Commissioner announced that the fourth quarter opioid-related deaths 
report will be released following this meeting. And it contains some encouraging news. Opioid-related 
overdose deaths in Massachusetts declined in 2017 by an estimated 8.3 percent over 2016 figures, 
marking the first time in many years in which those deaths have declined year over year.  
This is the third consecutive quarterly report where the number of estimated and confirmed opioid-
related deaths declined. 
Following the Commissioner’s opioid presentation, she announced that they launched a public 
awareness campaign targeting Latino parents of teens. The aim of the campaign is to raise awareness 
about prescription opioid addiction and help Latino parents learn how to talk about the dangers of 
opioid misuse with their kids. This new campaign includes a Spanish-language television spot which is 
airing on Spanish TV outlets in Boston and Springfield and also includes digital, YouTube, and Facebook 
ads. The Department has also produced a Spanish-language version of the Stop Addiction Before It 
Starts brochure which provides guidance to help parents get the conversation started with their teens. 
Commissioner Bharel then noted that the Bureau of Substance Addiction Services, is providing grants to 
Houses of Corrections to make available medication-assisted treatment and recovery services to people 
who are incarcerated and have an opioid use disorder. 
This month the program expanded to include the Suffolk County House of Correction, making it the sixth 
correctional facility to offer re-entry treatment and recovery services. The other five Houses of 
Correction are in Bristol, Franklin, Hampden, Middlesex and Worcester counties. 
Our data shows us that when someone is released from incarceration they are at an incredibly high risk 
of overdose. In fact, last year’s Chapter 55 report showed that the opioid-overdose-death-rate is 120 
times higher for people recently released from incarceration compared to the rest of the adult 
population. 
The population is now receiving this critical lifeline - access to medication-assisted treatment, case 
management services to facilitate a successful transition from a correctional services environment back 
into the community, and links to community-based treatment and recovery support services. 
The Commissioner then gave personnel updates. Ron Benham, current Director of the Bureau of Family 
Health and Nutrition will be retiring after 35 years with the state and 9 years here at DPH. She asked the 
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Council to join her in thanking Ron for his years of dedicated service to the health and wellness of 
children and families throughout the Commonwealth. Ron’s commitment to public service is 
inspirational. Ron’s last day with DPH will be Friday, February 27th. 
Craig Andrade, LATC, RN, DrPH, will be assuming the role of Director for the Bureau of Family Health and 
Nutrition on Tuesday, February 20th. Craig is currently the Director of the Division of Health Access 
(DOHA) within the Bureau of Community Health and Prevention.  
Eric Sheehan, Director of the Bureau of Healthcare Safety and Quality, will be leaving DPH on February 
23rd for a position in the private sector. Assistant Commissioner Elizabeth Chen will serve as Interim 
Bureau Director while we conduct a search for a new Bureau Director.  She asked the Council to join her 
in thanking Eric for his contributions while serving as Bureau Director, including the successful launch of 
the updated PMP system. 
Tom Land, Director of Special Analytic Projects for the Office of Population Health, will be leaving DPH 
on Feb 20th for a position at UMass Medical School.  The Commissioner thanked him for all of his work 
while at the Department, especially on the ground-breaking Chapter 55 Report.  
Dr. Al DeMaria, Medical Director, State Epidemiologist Bureau of Infectious Disease and Laboratory 
Sciences will be retiring at the end of June after serving the Department for decades.  For many if not all 
of us, Dr. DeMaria has been the face of infectious disease and an institution at the Department, and we 
are grateful for his dedication over the years.   
The Commissioner concluded her updates by asking the Council if they had any questions regarding her 
updates. 
Dr. David thanked the Commissioner and the Department for their work in assisting with the opioid 
curve trending downward. She inquired if the Department was making efforts to address the 
distribution of opioids from pharmaceutical companies. 
Commissioner Bharel replied from a pharmaceutical standpoint, the Drug Formulary Commission has 
come up with a list of non-opioid equivalents and drug deterrents. They also work with drug 
manufacturers as part of a drug take back program and she noted she can bring more details about that 
at a future meeting. She also briefly discussed prescribing practices. 
Dr. Bernstein discussed the increase in heroin use and noted the need to teach prescribers how to 
discuss addiction with those at risk. 
Ms. Blondet noted that more community health workers have become trained to use naloxone. She 
mentioned that it would be beneficial to do a targeted approach so that they can collect data on the 
work that community health workers are doing in the field. 
Commissioner Bharel replied that Ms. Blondet raised an excellent point and that they are an important 
part in the spectrum of care. 
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Mr. Lanzikos discussed the need for more education on the drug take back program. 
The Commissioner discussed the role of various groups in drug take back program. 
With no further questions, the Commissioner proceeded with the docket.  
1. ROUTINE ITEMS 
c. Record of the Public Health Council January 10, 2018 Meeting (Vote) 
 
Commissioner Bharel asked if any members had any changes to be included in the January 10, 2018 
meeting minutes.  
Seeing none, the Commissioner asked for a motion to accept the minutes. Mr. Lanzikos made the 
motion and Ms. Blondet seconded it. All other present members approved. 
 
2. DETERMINATIONS OF NEED 
a. AdCare, Inc. application for a transfer of ownership to AAC Holdings, Inc. (Vote) 
 
The Commissioner then invited Nora Mann, Determination of Need Program Director, and Rebecca 
Rodman, Deputy General Counsel, to the table to review the DoN staff recommendation for AdCare, 
Inc.’s application for a transfer of ownership to AAC Holdings, Inc.  
Upon the conclusion of their presentation, the Council was asked if they had any questions or 
comments. 
Representatives of the applicant were also available to answer any questions.  
Dean Cox asked for clarification on factor 3. 
Ms. Mann replied that factor 3 speaks to compliance and will be more relevant as we move forward 
because it’s not only compliance with other regulatory protocols but will also require a review of 
existing determinations of need.  
Dean Cox then asked if this applies to all AdCare facilities or just the facility in Worcester.  
Ms. Mann replied that AdCare has a variety of facilities both in Rhode Island the Commonwealth. Some 
of the facilities in Massachusetts are not subject to determination of need.  
Dean Cox then asked what AdCare’s role after this transfer.  
Ms. Mann replied that this is a stock transfer and deferred questions about the operations to the 
applicant.  
Dean Cox then asked for clarification on why HPC had not done a market review.. 
 8 
 
Ms. Mann replied that  certain healthcare transactions in Massachusetts must file a notice of material 
change with the Health Policy Commission. If HPC decides that the transaction is likely to have material 
effect on costs and markets in the Commonwealth they may issue a cost and market impact review. In 
this case, HPC declined to go forward the cost and market impact review.  
Dean Cox then asked what changes can be expected in the service delivery with this transfer. 
Ms. Mann deferred to the applicant but did note that in the application they made it very clear that 
there is no intent to change the nature of the services or the people for whom the services are being 
provided.  
Ms. Mann and Ms. Rodman were then joined by Michael Cartwright, CEO and Chairman of American 
Addiction Centers; Dr. Tom Doub, Chief Clinical Office and Chief Compliance Office for American 
Addiction Centers; Dr. Patrice Muchowski, Senior Vice President of Clinical Services for AdCare; and 
Jeffrey Hillis, President and General Counsel for AdCare.  
Dean Cox then asked what changes would occur in terms of delivery of services. 
Mr. Cartwright noted that in terms of management they are excited that the AdCare team will be joining 
American Addiction Centers. He noted that Jeff Hillis, will remain president of AdCare. 
Mr. Hillis also stated that he believes this is an opportunity to do effective research, outcome 
measurements and studies. He also discussed how AAC shares their passion for treating individuals who 
suffer from these disorders. 
Dr. Doub also discussed the use of technology and how they can improve treatment by utilizing it.  
Mr. Lanzikos asked if there were any negative reviews of AAC that have affected their operations in the 
past. 
Mr. Cartwright said while operating in 10 states he has never been suspended of license or had issues 
with government officials. 
Mr. Brindisi asked how do they intend to work with Massachusetts’ data analytics team so that there is 
proper trend analysis. 
Dr. Doub informed him of how data is integral and how they currently use it. 
Mr. Brindisi then asked about community engagement and what their intentions are.  
Mr. Hillis informed him that they are working with various stakeholders both community and 
government based. 
Dr. Muchowski also noted that community engagement is something that they are active in all the time. 
She discussed various programs they have been involved in and that AAC will continue to support them. 
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Dr. David asked if the applicant can report back in a year or two to assure services have continued to be 
provided.  
Ms. Rodman replied that with the new DoN regulations they will be reporting back yearly and that they 
can add this to the list of measures for their report. She also informed them that there are 
consequences to not complying as it would compromise future DoNs. 
Ms. Blondet inquired about their use of Medicare/Medicaid.  
Mr. Cartwright informed her that in his previous work experience he has worked with 
Medicare/Medicaid however, this is AAC’s first foray into Medicare/Medicaid. 
Dean Cox then echoed Dr. David’s concern about services continuing. 
Dr. Bernstein followed up discussing copays and the concern in assuring patients have access to 
treatment programs. 
Mr. Cartwright discussed cost savings from billing, IT services, marketing and how AdCare spent time 
researching AAC. 
Mr. Hillis noted that the tools used to save costs will not affect quality of service. 
Mr. Lanzikos asked what name will they be operating under in Massachusetts. 
Mr. Hillis replied that they will continue to utilize the AdCare name. 
Ms. Blondet asked if they had partnerships with the 18 ACOs. 
Mr. Hillis replied that they will be serving as an affiliated partner for behavioral health community 
partner services. 
They then discussed an ACO update in the regulation. 
With no further questions, Commissioner Bharel asked if there is a motion to accept the staff 
recommendation for approval of AdCare, Inc.’s application for a transfer of ownership to AAC Holdings, 
Inc. 
Dr. David leaves the room at 10:17am and returns at 10:19am. 
Mr. Lanzikos made the motion, Ms. Blondet seconded the motion. All present members approved. 
2. DETERMINATIONS OF NEED 
b. Partners HealthCare, Inc. application for a transfer of ownership with respect to the change in 
corporate control of the Massachusetts Eye and Ear Infirmary (MEEI). (Vote) 
The Commissioner then asked Ms. Mann to present the staff recommendation for Partners HealthCare, 
Inc.’s application for a transfer of ownership with respect to the change in corporate control of the 
Massachusetts Eye and Ear Infirmary (MEEI). 
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Joining Ms. Mann and Ms. Rodman was John Fernandez, President and Chief Executive Officer (CEO) of 
Massachusetts Eye and Ear; CarolAnn Williams, Chief Financial Officer and Vice President of Finance and 
Administration of MEEI; Peter K. Markell, Executive Vice President of Administration and Finance, Chief 
Financial Officer and Treasurer of Partners HealthCare; and David Torchiana, M.D., President and Chief 
Executive Officer of Partners HealthCare. 
Dr. David discussed a policy in which patient’s appointments are canceled if they are more than 3 times 
by 15 minutes late. She discussed concerns with lack of access for patients utilizing public 
transportation. 
Dr. Torchiana stated that he is not aware of the policy and it is not a Partners policy. He said that if this 
policy exists it’s probably practice specific but is not a Partners policy and will not be a MEEI policy. 
Dr. David refuted his statement and brought up personal experience.  
Dr. Torchiana stated that he will look into it. 
Ms. Lambert asked if they can speak to where Partners stands in incorporating an ACO model. 
Dr. Torchiana replied that they are one of the pioneering ACO and will be one of the larger Medicare 
ACOs as of March 1st. 
Ms. Lambert asked if he sees any obstacles to extending the service. 
Dr. Torchiana replied that they are not quite sure how the state ACO structure will play out or how 
closed or open the networks will be. They’re interested in having patients from other networks. 
Dean Cox asked how they can assure the things that Partners is noting will actually occur. 
Ms. Rodman replied that going forward, if this is approved, and if reports show that they are not 
complying for reasons that are not external then the Council is capable to penalize them. 
Mr. Markell reaffirmed the importance of building credibility with the Council and the importance of 
following the conditions that were set. 
Dr. Bernstein asked what are the market forces that put MEEI in the situation where they need to go to 
Partners.  
Mr. Fernandez replied that they have gone from 4 sites to 19 in the last 7 years and to continue to serve 
the state and region they decided they would need a partner to help them provide services and 
negotiate for the best terms for their patients.  
Ms. Lambert asked if there were any larger benefits to the community and if any outreach would be 
spread to additional communities in need. 
Mr. Fernandez replied that it’s an opportunity to expand using Partners real estate. 
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Mr. Lanzikos asked if there was any indication that there would be an adverse effect on other 
organizations. 
Ms. Mann replied that that was not a part of their analysis because it is not one of the factors. In terms 
of cost and market impact review, they were looking at the impact of the transaction of the market 
overall but did not reference any other specific providers, facilities or systems. 
Ms. Williams further discussed their role in in patient business. 
Ms. Blondet steps out at 11:11am and returns at 11:14am. 
With no further questions, the Commissioner asked if there is a motion to accept the staff 
recommendation for approval of Partners HealthCare, Inc.’s application for a transfer of ownership with 
respect to the change in corporate control of the Massachusetts Eye and Ear Infirmary (MEEI). 
Dr. Cunningham made the motion, Mr. Lanzikos seconded it. All present members approved. 
2.INFORMATIONAL PRESENTATIONS 
b. Informational presentation on DPH and Local Public Health Collaboration  
 
Commissioner Bharel then invited Kevin Cranston, Assistant Commissioner and Director of the Bureau 
of Infectious Disease and Laboratory Sciences, and Jana Ferguson, Director of the Bureau of 
Environmental Health, to the table.  Last month the Commissioner highlighted the excellent work of 
BIDLS and BEH that lead to the discovery of a new Salmonella strain while investigating raw frozen 
coconut meat and, ultimately, a decision by the distributor to recall all of the lots of product sold 
between January 3, 2017 and January 3, 2018.   
 
Mr. Brindisi leaves and does not return at 11:30am. 
 
Due to timing and to maintain quorum, no questions were asked by the Council following their 
presentation.  
 
The Commissioner asked for asked for a motion to adjourn. Dr. Bernstein made the motion Ms. Blondet 
seconded it. All present members approved. 
 
The Commissioner reminded the Council that the next meeting is Tuesday, March 6, 2018 at 9AM.  
 
The meeting adjourned at 11:40AM.   
 
 
 
